Homology Medicines, Inc.

We are mission-focused on developing
one-time treatments for genetic disorders

We are partners to the

rare disease community

Learn about our Clinical Trials >>>

We Are Applying our Broad Genetic Medicines

Platform to Treat, or Cure, Genetic Disease

Learn About Our Platform >>> View Our Pipeline >>>

Recent News >>>


August 14, 2023

Homology Medicines Reports Second Quarter 2023 Financial Results and Recent Highlights

July 27, 2023

Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU

July 27, 2023

Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU

We are

Homology

Learn about our Team and Mission >>>

Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology employee activities Homology employee activities
Homology Logo
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
      • Ava’s Story
      • Tia’s Story
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR
  • Culture & Careers
  • Contact Us

© Copyright 2023 Homology Medicines, Inc. All rights reserved.

  • Terms of Use
  • Accessibility Statement
MENU
  • We are Homology
    • We Are Homology
    • Leadership
    • Board of Directors
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
      • Ava’s Story
      • Tia’s Story
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR